UMS Integration Full Year 2024 Earnings: Revenues Disappoint

Simply Wall St

UMS Integration (SGX:558) Full Year 2024 Results

Key Financial Results

  • Revenue: S$242.1m (down 19% from FY 2023).
  • Net income: S$40.6m (down 32% from FY 2023).
  • Profit margin: 17% (down from 20% in FY 2023). The decrease in margin was driven by lower revenue.
  • EPS: S$0.057 (down from S$0.089 in FY 2023).
SGX:558 Revenue and Expenses Breakdown April 9th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

UMS Integration Revenues Disappoint

Revenue missed analyst estimates by 1.2%. Earnings per share (EPS) was mostly in line with analyst estimates.

The primary driver behind last 12 months revenue was the Semiconductor (Semicon) segment contributing a total revenue of S$204.6m (84% of total revenue). Notably, cost of sales worth S$126.0m amounted to 52% of total revenue thereby underscoring the impact on earnings. The largest operating expense was General & Administrative costs, amounting to S$35.8m (47% of total expenses). Explore how 558's revenue and expenses shape its earnings.

Looking ahead, revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 17% growth forecast for the Semiconductor industry in Asia.

Performance of the market in Singapore.

The company's shares are down 14% from a week ago.

Risk Analysis

You should learn about the 1 warning sign we've spotted with UMS Integration .

Valuation is complex, but we're here to simplify it.

Discover if UMS Integration might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.